After generating interest from the likes of Pfizer and GSK, Quotient Therapeutics’ somatic genomics platform has attracted another Big Pharma suitor in Merck & Co.  | Looking to devise new drug ...

The somatic genomics approach analyses naturally accumulated genetic mutations within individual patient tissue.

Somatic genetic mutations naturally accumulate over a lifetime, resulting in trillions of different genomes within an individual. Through its platform, Quotient interrogates patient tissue for these ...

IBD is a key R&D focus for MSD, whose pipeline in the indication is currently led by tulisokibart, an anti-TL1A antibody in ...

Merck & Co. will apply the somatic genomics platform Quotient Therapeutics to discover novel drug targets in inflammatory bowel disease (IBD), through a collaboration that could generate up to $2.2 ...

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom. Quotient, ...

Quotient’s complete fourth quarter and full year 2021 financial results and management commentary can be found by accessing the Company’s stockholder letter under Key Resources on the overview page of ...

👉 Learn how to find the derivative of a function using the quotient rule. The derivative of a function, y = f(x), is the ...